- Mytos inks multiple cell therapy manufacturing partnerships
- Hong Kong to host Asia-Pac longevity medicine summit
- Arrowhead inks $2b neurodegeneration deal with Novartis
- Wegovy cuts heart attack, stroke and death risk in CVD patients
- Social Security Praises Its New Chatbot. Ex-Officials Say It Was Tested But Shelved Under Biden.
- First patient dosed in Citryll’s Phase IIa trial of CIT-013 in RA
- Nanoscope strengthens global regulatory pathways for MCO-010
- Minovia lands funding to develop mitochondria biomarkers
- Trust: The missing ingredient in the longevity revolution
- Vutrisiran shows long-term benefit in ATTR-CM Phase 3 study
- In the dark for 11 million years: How blind cavefish rewrote evolution
- ProHealth Longevity launches pharmaceutical-grade methylene blue supplement
- Immortal Dragons backs Frontier Bio in advancing 3D biofabrication
- Immortal Dragons Backs Frontier Bio: Advancing 3D Biofabrication for Tissue Engineering
- Alnylam to advance zilebesiran into global phase 3 hypertension study
- The seven shifts needed to accelerate longevity science
- The missing pieces: What biomarkers of aging need to reach the clinic
- Lithium deficiency may be the hidden spark behind Alzheimer’s
- Banner year for Mesoblast with FDA approval and launch of Ryoncil
- Telomir Pharmaceuticals sees new in vitro evidence supporting Telomir-1 epigenetic potential
- Skin longevity biotech bags $20m for AI-powered ingredient discovery
- This simple diet could help protect memory, even with Alzheimer’s genes
- Minovia Therapeutics wins $350,000 grant for mitochondrial biomarkers
- Omada Health study shows virtual PT yields significant cost savings
- Portfolia backs Gameto in launch of women’s health fund IV
- Prolon Next Gen brings fasting science to the table
- Human Longevity taps precision proteomics for early detection
- Amylyx discontinues ORION program for AMX0035 in PSP
- Scientists discover brain aging protein, and reverse its effects
- Life Bio: epigenetic rejuvenation ‘transcends organs’